Skip to main content
Live · TradingView
Back to the NewsWire

Marketscreener

Published September 23, 2026 · Updated September 24, 2026

NeuroThera Labs Inc. And Clearmind Medicine Inc. Highlight Enhancement Of U.S. Patent ...

Read the full story at Marketscreener

ibogaine with N-acylethanolamines, including palmitoylethanolamide (?PEA?), NeuroThera?s proprietary technology. The applications cover potential.

Surfaced by this Google Alert

  • Ibogaine